Evidence map›Paper›PMID 35810241›Full record

ArticleInflammopharmacology2022

Correction to: Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases.

Shakti D Shukla, Madhur D Shastri, Swaroop K Vanka, Niraj Kumar Jha, Harish Dureja, Gaurav Gupta, Dinesh Kumar Chellappan, Brian G Oliver, Kamal Dua, E Haydn Walters

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Inflammopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 3 countries.

Shakti D ShuklaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia. shakti.shukla@utas.edu.au.ORCID http://orcid.org/0000-0002-5796-0171
Madhur D ShastriSchool of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia.
Swaroop K VankaPriority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
Niraj Kumar JhaDepartment of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, UP, 201310, India.
Harish DurejaDepartment of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, 124001, India.
Gaurav GuptaSchool of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, 302017, India.
Dinesh Kumar ChellappanDepartment of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
Brian G OliverSchool of Life Sciences, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
Kamal DuaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
E Haydn WaltersSchool of Medicine, University of Tasmania, Hobart, TAS, 7000, Australia. haydn.walters@utas.edu.au.
University of Technology Sydney · AUUniversity of Tasmania · AUIMU University · MYJaipur National University · INMaharshi Dayanand University · INSharda University · INUniversity of Newcastle Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35810241
PMCPMC9294012
OpenAlexW4284958208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.